Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT03017573
Recruiting
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Not applicable · France · 6 sites
Registry update: 3 Feb 2026
NCT03382158
Recruiting
International PPB/DICER1 Registry
Not applicable · United States · 1 site
Registry update: 26 Oct 2026
NCT04458792
Recruiting
Establishment of a Prospective Clinical-biological Database
Not applicable · France · 1 site
Registry update: 12 Feb 2025
NCT03838718
Recruiting
REtroperitoneal SArcoma Registry: an International Prospective Initiative
Not applicable · Australia, Canada, Germany, Spain, France, United Kingdom, Italy, South Korea, Poland, Slovenia, United States · 22 sites
Registry update: 12 Feb 2019
NCT02792270
Recruiting
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT02789384
Recruiting
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
Not applicable · France · 10 sites
Registry update: 8 Oct 2026
NCT02508038
Recruiting
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Phase 1 · United States · 1 site
Registry update: 27 Oct 2026
NCT02701153
Recruiting
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Not applicable · United States · 1 site
Registry update: 10 Mar 2026
NCT02811523
Recruiting
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
Phase 1 · Canada · 1 site
Registry update: 26 Nov 2025
NCT02677961
Recruiting
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Not applicable · United States · 1 site
Registry update: 11 Feb 2026
NCT03959800
Recruiting
Molecular Basis of Pediatric Liver Cancer
Not applicable · United States · 1 site
Registry update: 10 Aug 2026
2024-516078-31-00
Recruiting
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Phase 2/3 · Austria, Belgium, Czechia, Denmark, Spain, Finland, France, Italy, Netherlands, Norway · 54 sites
Registry update: 4 Dec 2024
NCT02390752
Recruiting
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Phase 1 · United States · 1 site
Registry update: 3 Nov 2026
NCT02275286
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Phase 1/2 · Spain, France, Italy · 17 sites
Registry update: 31 May 2023
NCT01790152
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Not applicable · Australia, Canada, Puerto Rico, United States · 79 sites
Registry update: 18 May 2026
NCT02013336
Recruiting
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Phase 1 · United States · 5 sites
Registry update: 8 Oct 2026
NCT02012699
Recruiting
Integrated Cancer Repository for Cancer Research
Not applicable · United States · 42 sites
Registry update: 29 Jun 2026
NCT01804634
Recruiting
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 · United States · 3 sites
Registry update: 13 Mar 2026
NCT01659203
Recruiting
Proton or Photon RT for Retroperitoneal Sarcomas
Phase 1/2 · United States · 10 sites
Registry update: 31 Jul 2026
NCT01772771
Recruiting
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Not applicable · United States · 1 site
Registry update: 21 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.